Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

NNC 38-1049

Inquiry
Cat. No.: OB0425LY-063
Synonyms: 757183-18-9; NNC-38-1049; NNC 38-1049; 1-(4-Chlorophenyl)-4-(4-cyclopentyl-1-piperazinyl)-1,4-butanedione; 1-(4-Chlorophenyl)-4-(4-cyclopentylpiperazin-1-yl)butane-1,4-dione; Piperazine, 1-(4-(4-chlorophenyl)-1,4-dioxobutyl)-4-cyclopentyl-
Size: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 200 mg; 500 mg
CAS No.: 757183-18-9
Compound CID: 9798429
NNC 38-1049

Specification

Description: NNC 38-1049 is a compound that targets diabetes and obesity and is a GLP-1 receptor agonist.
Formula Weight: 348.87
Applications: NNC 38-1049 can be used to study the treatment of metabolic diseases, especially in regulating insulin secretion and improving glycemic control.
Storage: Storage at -20°C.
Formula: C19H25ClN2O2
Appearance: Solid
Purity: 0.9984
Solubility: DMSO
Pathway: GPCR/G protein; Immunology/Inflammation; Neuronal signaling
Identity: Confirmed by NMR and LC-MS.
Target: Histamine receptor

Library Information

Solubility: DMSO
Inquiry

Copyright © Protheragen. All rights reserves.